Restricted accessResearch articleFirst published online 2002-7
Questions and Answers from the F.I.X. Epinephrine Interaction with Beta-Blocker;C. Difficle Prevention and Treatment;Levalbuterol Frequency;Protonix IV to PO
The Formulary Information Exchange (The F.I.X.) is an online drug information service available to subscribers to The Formulary Monograph Service at http://theformulary.com, or you may log on through drugfacts.com. In this column, we present samples of recent dialog on The F.I.X. If you would like more information on The Formulary Monograph Service or The F.I.X., please call 800-322-4349.
Get full access to this article
View all access options for this article.
References
1.
YocumM.W., ButterfieldJ.H., KleinJ.S.Epidemiology of anaphylaxis in Olmsted County: A population-based study.J Allergy Clin Immunol.1999; 104: 452–6.
2.
NeugutA.I., GhatakA.T., MillerR.L.Anaphylaxis in the United States: An investigation into its epidemiology.Arch Intern Med.2001; 161: 15–21.
3.
DiPiroJ.T., StaffordC.T., SchlesselmanL.S.Allergic and pseudoallergic drug reactions. In: DiPiroJ.T., TalbertR.L., YeG.C., eds. Pharmacotherapy: A Pathophysiologic Approach.4th ed.Stamford, CT: Appleton & Lange; 1999, 1393–1405.
4.
Clinical reviews: Anaphylaxis. In: LuckeW, LowensteinS, WiencekJG, eds. MICROMEDEX, Inc.Greenwood Village, CO (edition expires 6/2002).
5.
Metoprolol monograph.In: McEvoy GK, ed. AHFS Drug Information.Bethesda, MD: American Society of Health-System Pharmacists, Inc.; 2001, 1622–9.
6.
NewmanB.R., SchultzL.K.Epinephrine-resistant anaphylaxis in a patient taking propranolol hydrochloride [abstract].Ann Allergy.1981; 47: 35–7.
7.
AwaiL.E., MekoriY.A.Insect sting anaphylaxis and beta-adrenergic blockade: A relative contraindication [abstract].Ann Allergy.1984; 53: 48–9.
8.
WyattR.Anaphylaxis: How to recognize, treat, and prevent potentially fatal attacks.Postgraduate Medicine.1966; 100 (August). Available at: http://www.postgradmed.com/issues/1996/08_96/wyatt.htm. Accessed on March 30, 2002.
BeringerP.M., MiddletonR.K.Anaphylaxis and drug allergies. In: Koda-KimbleM.A., YoungL.Y., eds. Applied Therapeutics: The Clinical Use of Drugs.7th ed.New York, NY: Lippincott Williams & Wilkins; 2001, 4-1–4-23.
12.
American Academy of Allergy, Asthma, and Immunology.Media Resources: Position statement 17: B-Adrenergic blockers, immunotherapy, and skin testing.JACI.1989; 84: 129–30. Available at: http://www.aaaai.org/media/resources/position_statements/ps17.stm. Accessed on March 30, 2002.
13.
JohnsonS., SamoreM.H., FarrowK.A.Epidemics of diarrhea caused by a clindamycin-resistant strain of Clostridium difficile in four hospitals.New Eng J Med.1999; 341(22): 1645–60.
14.
Centers for Disease Control and Prevention.Preventing the spread of vancomycin-resistance: Report from the Hospital Infection Control Practices Advisory Committee.Fed Reg.1994; 59: 25758–63.
LaiK.K.Clostridium difficile-associated diarrhea: Epidemiology, risk factors, and infection control.Infect Control Hosp Epidemiol.1997; 18(9): 628–32.
17.
NelsonH.S., BenschG., PleskowW.W.Improved bronchodilation with levalbuterol compared with racemic albuterol in patients with asthma.J Allergy Clin Immunol.1998; 102: 943–52.
18.
HandleyD.The asthma-like pharmacology and toxicology of (S)-isomers of beta-agonists.J Allergy Clin Immunol.1999; 104(suppl): 69–76.
